Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
06:01AM 11/20/09
Genzyme's Termeer: Worst Biotech CEO of '09
Genzyme CEO Henri Termeer is Adam Feuerstein's Worst Biotech CEO of the Year for 2009.
12:31PM 11/17/09
Takeout Rumors Lift Dendreon, Bio Stocks: BioBuzz
On a strong day for the sector, the buyout rumors are buzzing
03:18PM 09/14/09
Auxilium Shares Higher On FDA Drug Review: BioBuzz
FDA doesn't raise new safety issues for Auxilium's hand treatment
11:01AM 09/14/09
XOMA to Repay Goldman Loan: BioBuzz
Drug company removes overhang on balance sheet
08:55AM 09/14/09
Cell Therapeutics CEO Sells Stock: BioBuzz
Jim Bianco unloads 30% of holdings days after investor meeting
06:40AM 09/14/09
Biotech Stock Mailbag: Genta Takes Another Stab
Readers weigh in on Genta, Opexa, Osiris, Vivus and Antigenics.
07:00AM 09/11/09
BioTech Tops List: Stock Search
Bio tech names lead the top 10 list and Debra Borchardt covers the reasons why.
04:58PM 09/08/09
GE, Kraft, Atheros, Harley-Davidson Big Movers
General Electric, Kraft, Atheros, Harley-Davidson, Hecla Mining are among big market movers
04:54PM 09/08/09
Genzyme Slides On Prochymal Trial Failures
Genzyme slips after partner says stem cell drug did not reach goals in 2 clinical studies
03:56PM 09/08/09
Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz
Investors waiting for government to buy emergency stockpile of peramivir
02:27PM 09/08/09
Osiris Drug's Failure Was Easy to Envision
Osiris Therapeutics' shoddy work and shortcuts in its previous clinical trials for stem cell drug Prochymal led to the failure of two late-stage trials.
11:37AM 09/08/09
Spectrum shares fall despite drug approval: BioBuzz
Uncertainty over Zevalin's relaunch likely weighing on stock price
11:18AM 09/08/09
Osiris' Prochymal Fails 2 Late-stage Studies
Osiris Therapeutics' Prochymal misses goals in 2 late-stage clinical trials; shares plunge
09:53AM 09/08/09
Osiris Stem Cell Drug Fails: BioBuzz
Negative results announced from two phase III studies in graft-versus-host-disease
08:44AM 09/08/09



Connect with TheStreet